Concomitant Transthyretin Amyloid Cardiomyopathy in Patients With Multiple Myeloma
ATTR-CM can occur in patients with multiple myeloma. Endomyocardial biopsy is essential to accurately distinguish ATTR-CM from AL-CM in the presence of plasma cell dyscrasia and to ensure appropriate and timely treatment.
Authors
- Rashid Alhusain (ORCID: https://orcid.org/0000-0003-1074-3978)
- Nabeel Aslam (ORCID: https://orcid.org/0000-0003-2735-0951)
- Taimur Sher (ORCID: https://orcid.org/0000-0003-1133-3970)
- Jordan Ray (ORCID: https://orcid.org/0000-0001-7583-3355)
- Juan Leoni (ORCID: https://orcid.org/0000-0001-7820-3842)
- Mohamed K. Ibrahim (ORCID: https://orcid.org/0000-0003-0519-8936)
- José Nativi Nicolau
- Grace Lin (ORCID: https://orcid.org/0000-0001-9222-2767)
- Melissa Lyle (ORCID: https://orcid.org/0000-0002-5671-5596)
- Awais Malik
Institutions
- Jacksonville College (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1016/j.jaccas.2025.105755
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00